In vivo experimental, data indicated that TIM‐4 overexpression elevated the Treg proportion, while decreased the proportion of CD8+Tc cells, indicating that TIM‐4 affected CD8+Tc cells through Treg, and CD8+ Tc cells' killing effect on tumor cells ultimately affected tumor growth. Here, TIMD4 is linked to neoplasm.